Patanjali claim to make first Ayurvedic COVID-19 medicine, 100 pc recovery within 3-7 days

Patanjali claim to make first Ayurvedic COVID-19 medicine

  • Patanjali launches first Ayurvedic COVID-19 medicine
  • Claims 100 pc recovery within 3-7 days

The Ayurvedic firm Patanjali launched medicine ‘Coronil and Swasari’ on Tuesday. And what it claims is the Ayurvedic cure for treating COVID-19, which they said has been shown 100 percent favorable results during clinical trials on affected patients, at Patanjali Yogpeeth in Haridwar, Uttarakhand, India.

Proud to announce that the first Ayurvedic, clinically controlled trial based evidence and research-based medicine has been prepared by the combined efforts of Patanjali Research Centre and NIMS: Ramdev

First Ayurvedic COVID-19 medicine has shown a 100 percent recovery rate within 3-7 days: claims Yog Guru Ramdev

“The whole country and the world were waiting for medicine or vaccine for corona. We are proud to announce that the first Ayurvedic COVID-19 medicine, clinically controlled trial based evidence and research-based medicine has been prepared by the combined efforts of Patanjali Research
Centre and NIMS
,” Yoga Guru Ramdev said at the press conference adding that it has shown “100 percent recovery rate within 3-7 days.”

“We conducted two trials of these, first clinical controlled study, which took place in Delhi, Ahmedabad, among many other cities: Ramdev”

“We are launching COVID medicine Coronil and Swasari today. We conducted two trials of these, first clinical controlled study, which took place in Delhi, Ahmedabad, among many other cities. Under this 280 patients were included and 100 percent of those recovered. We were able to control Corona and its complications in this. After this the all-important clinical control trial was conducted,” he added.

Patanjali’s Divya Corona kit

He thanked the Director, National Institute of Medical Sciences, NIMS University, Jaipur, Dr. Balbir Singh Tomar, and all other doctors and scientists for their help in creating the medicine.

“With the help of NIMS, Jaipur we conducted the clinical control study on 95 patients. The biggest thing which came out of this is that within three days 69 percent of patients recovered and became negative from positive (cases) and within seven days 100 percent of them became negative,” he added.

Ramdev also said that necessary approvals for conducting the trials of medicine on patients had been taken from competent authorities.

Acharya Balkrishna, Chief Executive Officer (CEO) of Patanjali, was also present at the occasion of the launch along with other officials and representatives who had taken part in the preparation of the medicine.

Also read: What is a pulse oximeter and how can it be helpful to detect COVID-19 pneumonia?


Leave a Reply

Your email address will not be published.